Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Liabilities from Discontinued Operations (2009 - 2018)

Charles River Laboratories International (CRL) posted Liabilities from Discontinued Operations of $3.5 million for Q1 2018, down 11.82% on a QoQ basis from $3.9 million in Q4 2017, and down 34.42% year-over-year from $5.3 million in Q1 2017.

Analysis

Charles River Laboratories International (CRL) Liabilities from Discontinued Operations (2009 - 2018) Analysis & Trends

Charles River Laboratories International has reported Liabilities from Discontinued Operations for 10 years, with the latest figure at $3.5 million in Q1 2018.

  • On a quarterly basis, Liabilities from Discontinued Operations fell 34.42% year-over-year to $3.5 million in Q1 2018; TTM through Mar 2018 was $3.5 million, a 34.42% decrease from a year earlier, with the FY2017 full-year figure at $3.9 million, down 31.69% from the prior year.
  • Liabilities from Discontinued Operations was $3.5 million for Q1 2018 at Charles River Laboratories International, down from $3.9 million in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was $8.4 million in Q4 2014, with the low at $3.5 million in Q1 2018.
  • Average Liabilities from Discontinued Operations over 5 years is $6.5 million, with a median of $7.1 million recorded in 2015.
  • The sharpest annual moves came in 2015 and 2018: Liabilities from Discontinued Operations advanced 4.23% in 2015, then sank 34.42% in 2018.
  • Over 5 years, Liabilities from Discontinued Operations stood at $8.4 million in 2014, then retreated by 5.59% to $7.9 million in 2015, then retreated by 26.86% to $5.8 million in 2016, then plunged by 31.69% to $3.9 million in 2017, then decreased by 11.82% to $3.5 million in 2018.
  • The last three Liabilities from Discontinued Operations figures came in at $3.5 million (Q1 2018), $3.9 million (Q4 2017), and $4.4 million (Q3 2017), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 3.48 Mn
Dec 30, 2017 3.94 Mn
Sep 30, 2017 4.40 Mn
Jul 1, 2017 4.85 Mn
Apr 1, 2017 5.30 Mn
Dec 31, 2016 5.77 Mn
Sep 24, 2016 6.21 Mn
Jun 25, 2016 7.09 Mn
Mar 26, 2016 7.42 Mn
Dec 26, 2015 7.89 Mn
Sep 26, 2015 7.14 Mn
Jun 27, 2015 7.55 Mn
Mar 28, 2015 7.94 Mn
Dec 27, 2014 8.36 Mn
Sep 27, 2014 7.88 Mn
Jun 28, 2014 8.27 Mn
Mar 29, 2014 7.62 Mn
Dec 28, 2013 8.08 Mn
Sep 28, 2013 10.48 Mn
Jun 29, 2013 11.26 Mn